v3.26.1
STATEMENTS OF CASH FLOW - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
CASH FLOW FROM OPERATING ACTIVITIES:      
Net loss $ (13,220) $ (11,053) $ (11,286)
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation 150 171 111
Capital loss 9 5 0
Share based compensation expenses 3,575 1,892 1,427
Share based compensation – placement agent warrants 0 0 59
Evaluation of financial liability at fair value (720) 47 (306)
Expiration of financial liability 0 (11) 0
Issuance cost 0 0 205
Issuance of ordinary shares - advisor fees 116 62 0
Prepayments of lease liabilities 0 (9) (7)
Decrease (increase) in right of use assets, net 99 31 (5)
Decrease (increase) in other current assets 78 (84) 190
(Decrease) increase in trade accounts payables (47) (44) 46
(Decrease) increase in other accounts payable (58) 118 (190)
(Increase) decrease in inventory (291) (444) 0
Unrealized foreign exchange (gain) loss (25) (55) 65
Financial expenses due to commitment fee – Standby Equity Purchase Agreement (SEPA) 250 0 0
Issuance of ordinary shares - commitment fee (SEPA) 223 0 0
Net cash used in operating activities (9,861) (9,374) (9,691)
CASH FLOW FROM INVESTING ACTIVITIES:      
Purchase of property, plant, and equipment (103) (164) (206)
Change in deposits, net 668 1,652 4,800
Net cash provided by investing activities 565 1,488 4,594
CASH FLOWS FROM FINANCING ACTIVITIES:      
Issuance of ordinary shares, pre-funded warrants and ordinary warrants, net 1,759 7,898 3,424
Exercise of options 10 2 3
Exercise of warrants and pre-funded warrants, net 912 2 0
Issuance of ordinary shares (issuances pursuant to an at-the-market facility), net 4,646 0 26
Net cash provided by financing activities 7,327 7,902 3,453
Effect of exchange rate changes on cash and cash equivalents 25 55 (65)
Net increase (decrease) in cash and cash equivalents and restricted cash (1,969) 16 (1,644)
Cash, cash equivalents and restricted cash at the beginning of the period 5,201 5,130 6,839
Cash, cash equivalents and restricted cash at the end of the period 3,257 5,201 5,130
Cash and cash equivalents 3,159 5,111 5,041
Restricted cash 98 90 89
Total cash, cash equivalents and restricted cash shown in the statement of cash flows 3,257 5,201 5,130
Other receivable in connection to December private placement 0 70 0
Accrued issuance expenses (43) (220) 0
Financial liability- placement agent fee (Note 10-A) 0 (69) 0
Share based compensation- placement agent warrants against additional paid in capital (Note 11) 0 (254) (73)
Total non cash transactions (43) (473) (73)
Interest paid $ 65 $ 72 $ 93